Christopher Lee
Gestionnaire de Portefeuille-Actions chez EARNEST Partners LLC
Profil
Dr. Christopher Lee is an Investment Manager at EARNEST Partners LLC.
He is a member of the investment team at EARNEST Partners.
Prior to joining EARNEST Partners, he was a Scientific Strategy Analyst at CytoAgents.
Prior to that, he worked as a consultant advising the CDC, where he developed protocols for automated high-throughput neutralization assay for its Viral Vaccine-Preventable Branch.
Dr. Lee holds a Ph.D.
in Microbiology and Immunology from the University of Pittsburgh.
He also holds a B.S.
in Microbiology from the University of Georgia.
Postes actifs de Christopher Lee
| Sociétés | Poste | Début |
|---|---|---|
EARNEST Partners LLC
 EARNEST Partners LLC Investment ManagersFinance EARNEST Partners LLC is a SEC-registered investment advisor headquartered in Atlanta, Georgia. The firm was founded in 1999 by Paul Viera Jr. They are a subsidiary of Westchester Ltd. LLC, owned by Pev Trust. EARNEST Partners provides investment advice to various types of clients. | Gestionnaire de Portefeuille-Actions | 01/09/2021 |
Formation de Christopher Lee
| University of Georgia | Undergraduate Degree |
| University of Pittsburgh | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
EARNEST Partners LLC
EARNEST Partners LLC Investment ManagersFinance EARNEST Partners LLC is a SEC-registered investment advisor headquartered in Atlanta, Georgia. The firm was founded in 1999 by Paul Viera Jr. They are a subsidiary of Westchester Ltd. LLC, owned by Pev Trust. EARNEST Partners provides investment advice to various types of clients. | Finance |
